proline has been researched along with isoleucyl-prolyl-proline in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Jakimova, B; Kolev, T; Koleva, BB; Stoineva, I; Tchorbanov, B | 1 |
Brayden, DJ; Byrne, HJ; FrÃas, JM; Gleeson, JP; Khalid Danish, M; Ryan, SM | 1 |
2 other study(ies) available for proline and isoleucyl-prolyl-proline
Article | Year |
---|---|
Stabilization of neutral NH2-R-COOH form of the antihypertensive peptides L-Valyl-L-Prolyl-L-Proline and L-Isoleucyl-L-Prolyl-L-Proline.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chromatography, High Pressure Liquid; Isoleucine; Models, Molecular; Normal Distribution; Nuclear Magnetic Resonance, Biomolecular; Oligopeptides; Proline; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Tandem Mass Spectrometry; Valine | 2009 |
Formulation, Characterisation and Evaluation of the Antihypertensive Peptides, Isoleucine-Proline-Proline and Leucine-Lysine-Proline in Chitosan Nanoparticles Coated with Zein for Oral Drug Delivery.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Caco-2 Cells; Chitosan; Drug Carriers; Humans; Leucine; Lysine; Nanoparticles; Oligopeptides; Particle Size; Peptides; Proline; Rats; Rats, Inbred SHR; Zein | 2022 |